Therapy non-responder: FDA reporting patterns
43,984 FDA FAERS reports mention Therapy non-responder. 26,839 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 3,983 reports
- Apremilast: 3,775 reports
- Methotrexate: 3,317 reports
- Adalimumab: 3,182 reports
- Rituximab: 3,092 reports
- Prednisone: 2,933 reports
- Treprostinil: 2,661 reports
- Infliximab: 2,597 reports
- Tocilizumab: 1,973 reports
- Hydroxychloroquine: 1,917 reports
- Abatacept: 1,903 reports
- Leflunomide: 1,791 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.